ClinConnect ClinConnect Logo
Search / Trial NCT04487782

Pragmatic Weight Loss Intervention During Menopause

Launched by KARA MARLATT · Jul 22, 2020

Trial Information

Current as of October 12, 2025

Completed

Keywords

ClinConnect Summary

This is a participatory research study which will enroll women (n of up to 56) with experience of menopause to help identify preferred strategies (modalities) for weight loss, which will combine calorie (dietary) restriction and exercise tactics.

Aim 1: Explore attitudes and perceptions about weight gain during the menopause transition, and identify weight loss strategies from the patient (peer) perspective.

- The investigators will apply these learnings: 1) to understand barriers for weight management during menopause; 2) to establish strategies to guide retention; 3) to finalize the int...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age 45 to 60 years
  • * Currently experiencing (or have experienced) the one of the following menopause-related traits:
  • Vasomotor symptoms including hot flashes and/or night sweats
  • Irregular menstrual cycle
  • African-American (Black) or Caucasian (White) race
  • Self-report having a desire to lose (or maintain) weight during menopause
  • Willing to be recorded during the focus group for transcription purposes
  • Exclusion Criteria:
  • Are pre-menopausal
  • Non-English speaking

About Kara Marlatt

Kara Marlatt is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, Kara Marlatt collaborates with leading healthcare professionals and institutions to design and implement rigorous clinical trials. The organization prioritizes ethical standards and regulatory compliance, ensuring the safety and well-being of participants while generating valuable data that can drive progress in various therapeutic areas. Through its comprehensive approach and unwavering dedication to excellence, Kara Marlatt aims to contribute significantly to the evolving landscape of healthcare.

Locations

Baton Rouge, Louisiana, United States

Patients applied

0 patients applied

Trial Officials

Kara L Marlatt, PhD, MPH

Principal Investigator

Pennington Biomedical Research Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials